• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Electrifying Healthcare: A Look at Electronics Manufacturing Services for Medtech

    Smooth Operator: Addressing Machining's Talent Gap

    Valued R&D: The Transformation of Medical Device Research and Development

    Additive Manufacturing: A Tool for Driving Innovation

    Layering Metal: Additive Manufacturing in Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Robotic Sensor Can Spot Reproductive Health Problems in Real-Time

    First Motor-Controlled Heart Valves Implanted in Europe

    Micro Interventional Devices and Neovasc Settle TMVR Lawsuit

    FDA Clears New Soft Tissue Visualization for ViewRay's MRIdian System

    IZI Medical Products Acquires Quick-Core Biopsy, Breast Localization Needle Assets From Cook Medical
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Electrifying Healthcare: A Look at Electronics Manufacturing Services for Medtech

    Smooth Operator: Addressing Machining's Talent Gap

    Valued R&D: The Transformation of Medical Device Research and Development

    Additive Manufacturing: A Tool for Driving Innovation

    Layering Metal: Additive Manufacturing in Medtech
    Top 30 Medical Device Companies
    Top Top 30
    Top 30 Global Medical Device Companies

    1. Medtronic plc

    2. Johnson & Johnson

    3. GE Healthcare

    4. Royal Philips
    Market Data
    Datawatch Column
    Salary Survey
    White Papers
    Top Research
    Discerning Medtech’s Path in 2019

    Disrupting the Outsourcing Model

    Election Impact and the Beginning of the 116th Congress

    Is Your Packaging Provider Prepared If Disaster Strikes?

    A Primer for Manufacturers Adjusting to Value-Based Healthcare
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Propel

    Ulbrich Stainless Steels & Special Metals Inc.

    Forefront Medical Technology

    K-Tube Technologies

    Pulse Systems
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Help Wanted

    Is VR the Solution for Addressing Chronic Pain?

    Design Sophisticate

    Sintered or Expanded—Which PTFE Is Best Suited for Your Device?

    Best Practices Spotlight: How to Grow Your Products Globally
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Marox Corporation

    Spectrum Plastics Group

    Pulse Systems

    EG-GILERO

    K-Tube Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Salary Survey
      • Market Data
      • Datawatch Column
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Boston Scientific Acquires nVision Medical for Up to $275M

    Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer.

    Related CONTENT
    • MPO Summit Conference Program Notebook
    • FDA Warns Magellan Diagnostics of Possible Federal Law Violations
    • FDA Commissioner Declares New Steps to Advance Medical Device Innovation
    • Scenes from the MPO Summit 2017
    • Medtech Mettle: The 2017 Year in Review
    PR Newswire04.16.18
    Boston Scientific announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health. nVision developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. Recent studies have confirmed that several major types of ovarian cancer appear to originate from the fallopian tubes.1
     
    Ovarian cancer is the fifth leading cause of cancer death among women. More than two million women in the U.S. are at high risk for developing the disease, which occurs more frequently in those with a family history or with BRCA1 or 2 gene mutations.2,3 Women with ovarian cancer are often asymptomatic until late in the course of the disease.4 There are no recommended early screening tests and, to date, there has been no effective way to biopsy cells in the fallopian tubes. As a result, every year, approximately 300,000 women elect to have preventative removal of their ovaries and fallopian tubes to reduce the risk of developing ovarian cancer.5
     
    "We estimate the near-term market opportunity to be $500 million with the potential to grow to $2 billion as this device is used by more gynecologists to help even more women," said Dave Pierce, executive vice president and president, MedSurg, Boston Scientific. "We are committed to expanding our women's health portfolio and driving clinical research that will help deliver innovative options for the prevention and treatment of gynecological cancer."
     
    Initial clinical research has demonstrated that the nVision device effectively collects cells which, when tested, correlate with a post-surgery definitive diagnosis of ovarian cancer. Boston Scientific plans to conduct additional clinical research with the nVision device to further establish how the cells it collects from the fallopian tubes can be used to render a diagnosis prior to surgery and help in the decision-making process for women at increased risk for ovarian cancer.
     
    "I started nVision with a goal of creating a tool to address an unmet need in women's health," said Surbhi Sarna, founder and chief executive officer, nVision. "I am proud of our achievements in advancing efforts to help with the early detection of ovarian cancer and look forward to working with Boston Scientific to move this technology forward."
     
    Physicians often counsel women to take preventive action as the majority of ovarian cancer diagnoses are made at stage three or four of the disease, considering that the survival rate at stage three is approximately 30 percent and at stage four is estimated to be 17 percent.1,6 While removal of the ovaries and fallopian tubes can reduce the likelihood of developing cancer, it also increases the risk that women will develop cardiovascular issues or have cognitive impairment and prevents child bearing.1
     
    "We are excited to develop this technology that one day may play an important role in early detection of the disease and the prevention of unnecessary surgeries, while also serving as a foundation for our broader oncology initiatives in both diagnostics and therapeutics," said Professor Ian T. Meredith, AM, executive vice president and global chief medical officer, Boston Scientific.
     
    The transaction consists of an upfront cash payment of $150 million, and up to an additional $125 million in potential clinical and commercial milestones over four years. The acquisition is expected to be immaterial on an adjusted basis in 2018 and 2019, and accretive thereafter (dilutive on a GAAP basis through 2020 and less accretive thereafter due to amortization expense and acquisition costs).
     
    References
    1https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Salpingectomy-for-Ovarian-Cancer-Prevention
    2http://www.vervemagazine.in/people/surbhi-sarna-nvision-medical-ovarian-cancer
    3https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946
    4https://www.aafp.org/afp/2016/0601/p937.html
    5http://journals.sagepub.com/doi/abs/10.2217/17455057.5.1.39
    6https://www.cancer.org/cancer/ovarian-cancer/causes-risks-prevention/risk-factors.html
    Related Searches
    • first
    • u.s. food and drug administration
    • market
    • diagnostics
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    FDA FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    Boston Scientific Acquires Securus Medical Group Boston Scientific Acquires Securus Medical Group
    Edwards Wins TAVR Patent Clash Against Boston Scientific Edwards Wins TAVR Patent Clash Against Boston Scientific
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    Boston Scientific Buys NxThera for Up to $406M Boston Scientific Buys NxThera for Up to $406M
    4Tech Inc. Appoints President and CEO 4Tech Inc. Appoints President and CEO
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
    Boston Scientific Acquires EMcision Ltd. Boston Scientific Acquires EMcision Ltd.
    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    R&D Reboot: Leveraging New Strategies for Innovation Creation R&D Reboot: Leveraging New Strategies for Innovation Creation
    Cibiem Appoints Former Boston Scientific CEO to its Board Cibiem Appoints Former Boston Scientific CEO to its Board
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    FDA Approves Boston Scientific FDA Approves Boston Scientific's Vercise Deep Brain Stimulation System
    FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    Employee Feedback Should Be Part of a Product Safety Plan Employee Feedback Should Be Part of a Product Safety Plan

    Related Breaking News

    • Diagnostics | Electronics | Patient Monitoring
      Robotic Sensor Can Spot Reproductive Health Problems in Real-Time

      Robotic Sensor Can Spot Reproductive Health Problems in Real-Time

      The sensor measures hormones that affect fertility, sexual development, and menstruation more quickly and cheaply than current methods.
      Imperial College London 02.21.19

    • Diagnostics
      FDA Clears New Soft Tissue Visualization for ViewRay

      FDA Clears New Soft Tissue Visualization for ViewRay's MRIdian System

      Proprietary technology from ViewRay enables imaging and treatment enhancements.
      PR Newswire 02.21.19

    • Diagnostics | Patient Monitoring | Software & IT
      Medtronic

      Medtronic's Personalized Closed Loop Insulin Pump System Wins Breakthrough Status

      The PCL technology is designed to automate insulin delivery in a way that is real-time, personalized, and adapts to the user.
      GlobeNewswire 02.19.19


    • Diagnostics
      Hologic’s Aptima HIV-1 Quant Dx Assay Gains Two CE Marks

      Hologic’s Aptima HIV-1 Quant Dx Assay Gains Two CE Marks

      The new CE marks make Aptima HV-1 the first and only dual-claim assay for both viral load and early infant diagnosis.
      Business Wire 02.14.19

    • Diagnostics
      Biosensor Detects Down Syndrome DNA

      Biosensor Detects Down Syndrome DNA

      Fast, sensitive, and cost-effective test could detect elevated DNA concentrations of chromosome 21 DNA in pregnant women's blood.
      American Chemical Society 02.13.19

    • Diagnostics
      Hologic Launches Unifi Analytics Business Intelligence Tool

      Hologic Launches Unifi Analytics Business Intelligence Tool

      Solution is designed to maximize efficiency and reduce downtime in the mammography suite.
      Hologic Inc. 02.11.19


    • Diagnostics | Software & IT
      Smartphone Use Risks Eye Examination Misdiagnosis

      Smartphone Use Risks Eye Examination Misdiagnosis

      Research finds that calibration of phone cameras is vital to capture accurate data.
      Anglia Ruskin University 02.11.19

    • Cardiovascular | Diagnostics | Patient Monitoring
      Philips Launches EPIQ Elite Ultrasound System for General Imaging and OB-GYN

      Philips Launches EPIQ Elite Ultrasound System for General Imaging and OB-GYN

      EPIQ Elite offers a range of diagnostic ultrasound solutions tailored to the needs of specific medical specialties.
      Philips 02.11.19

    • Diagnostics | Neurological | Software & IT
      Cognoa

      Cognoa's Autism Diagnostic & Digital Therapeutic Devices Win FDA Breakthrough Status

      Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children.
      GlobeNewswire 02.11.19


    • Diagnostics
      FDA Clears Siemens Healthineers

      FDA Clears Siemens Healthineers' MAGNETOM Lumina 3T MRI System

      70-cm Open Bore system with BioMatrix technology expands clinical application by delivering productivity gains and reproducible results.
      Siemens Healthineers 01.31.19

    • Diagnostics
      FDA OKs Kurin Lock with Peripheral IV Infusion Set

      FDA OKs Kurin Lock with Peripheral IV Infusion Set

      New Kurin PIV18 peripheral IV configuration with an extension set can be used for infusion.
      Business Wire 01.30.19

    • Diagnostics
      Ortho Clinical Diagnostics Welcomes New Chairman & CEO

      Ortho Clinical Diagnostics Welcomes New Chairman & CEO

      Current president Robert Yates to become Chairman and CEO of Ortho; Dr. Martin Madaus to retire.
      PR Newswire 01.29.19

    • Diagnostics | Neurological
      FDA Awards Breakthrough Status to Blood Test to Determine Alzheimer

      FDA Awards Breakthrough Status to Blood Test to Determine Alzheimer's Risk

      Breakthrough Device Designation granted to C2N’s proprietary blood test for the initial screening of amyloid pathology in the brain associated with Alzheimer's.
      Business Wire 01.29.19

    • Diagnostics | Neurological | Software & IT
      New Non-Invasive Tool Will Help Detect Alzheimer

      New Non-Invasive Tool Will Help Detect Alzheimer's in Its Early Stages

      The ALTEA tool visualizes and segments MRI scans to analyze cerebral textures.
      Asociacion RUVID 01.29.19

    • Diagnostics
      FDA OKs Hologic

      FDA OKs Hologic's Test to Detect Mycoplasma Genitalium STI

      This is the first test authorized by the FDA to test for the M. gen. bacterium.
      PR Newswire 01.24.19


    Breaking News
    • Robotic Sensor Can Spot Reproductive Health Problems in Real-Time
    • First Motor-Controlled Heart Valves Implanted in Europe
    • Micro Interventional Devices and Neovasc Settle TMVR Lawsuit
    • FDA Clears New Soft Tissue Visualization for ViewRay's MRIdian System
    • IZI Medical Products Acquires Quick-Core Biopsy, Breast Localization Needle Assets From Cook Medical
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • Electrifying Healthcare: A Look at Electronics Manufacturing Services for Medtech
    • Smooth Operator: Addressing Machining's Talent Gap
    • Valued R&D: The Transformation of Medical Device Research and Development
    • Additive Manufacturing: A Tool for Driving Innovation
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login